Peptides for Muscle Growth

Peptides for Muscle Growth in This Catalog

Thirty vials and blends sit here.

Dragon Pharma covers the widest range, from Ipamorelin 5mg and Sermorelin 5mg to the two blends at 10 mg. Generic Peptides, British Dragon, AxioLabs and Kalpa Pharmaceuticals repeat the group in other pack sizes.

How to Choose for a Growth Goal

For a first protocol, choose one arm and stay with it. A single GHRH analog injected daily is the easiest thing to read, and a ghrelin-receptor secretagogue on top is the most common combination. Where the goal is tissue repair rather than growth, the sister shelf is Peptides for Recovery.

Where a longer, flatter release is wanted, the DAC version of CJC-1295 is the option. IGF-1 LR3 works systemically, so blood glucose belongs in the plan.

Protocol and Length

Amounts Used in Research Protocols

None of these peptides has an approved sports dose, so every figure here is a vendor or research convention from the project fact sheets. Ipamorelin is described at 200 to 300 mcg per injection two or three times a day, CJC-1295 without DAC at 100 to 200 mcg once to three times a day, and hexarelin at 100 to 200 mcg once or twice a day. For tesamorelin the firm numbers come from the approved product, 1.4 mg and 2 mg daily. IGF-1 LR3 is described at 20 to 50 mcg a day and PEG MGF at 200 to 400 mcg once to three times a week.

How Long a Protocol Runs

Releasing peptides are run as long blocks rather than short cycles. Vendor material for ipamorelin and sermorelin gives 12 to 16 weeks followed by a four to six week break, and the tesamorelin and ipamorelin blend 8 to 12 weeks. Hexarelin is run in 4 to 6 week blocks with 6 to 8 weeks off, because it loses strength without a pause.

Injection Timing and Schedule

The releasing peptides are subcutaneous injections on an empty stomach, and the evening injection is the anchor of most protocols. Because ipamorelin clears in about two hours and GHRP-2 in under an hour, one daily injection does not hold a level.

Support and Monitoring

The risks here are not liver risks, as they can be with oral steroids. What appears in the literature is water retention, joint and muscle ache, headache and, with the ghrelin-receptor peptides, hunger that works against a diet. IGF-1 and fasting glucose are the markers named for the releasing peptides and for IGF-1 LR3, and glucose deserves attention there because a hypoglycemic response is the class risk. Sleep quality, heart rate and joint comfort are the daily signals. It is also worth keeping the group separate from injectable steroids, because the monitoring and the recovery questions are not the same.

Common Mistakes

The first mistake is treating a peptide protocol as a shortcut past food and training. These materials work through the body's own growth hormone signalling, and that signal is small next to a calorie surplus and progressive training. A mass-building phase is still built on food and volume, and these vials are an addition to it at best.

The rest follow from impatience. Mixing two arms by hand and guessing the ratio is avoidable when a prepared blend documents the split, and starting high removes any way of knowing what a lower amount would have done.